- In September 2023, Stryker launched the PROstep MIS Lapidus, a novel internal fixation system designed for the treatment of bunions. This system facilitates a minimally invasive surgical approach to address hallux valgus deformity and achieve fusion of the first metatarsal cuneiform joint
- In September 2023, Enovis (DJO, LLC) opened a new manufacturing facility in the U.S., dedicated to producing reconstructive knee, hip, and shoulder implants
- In October 2023, DePuy Synthes received U.S. FDA 510k clearance for its lower extremity anatomic plating system, TriLEAP. This modular system is specifically designed to meet the complex needs of podiatric medicine doctors, orthopedic surgeons, and specialists in foot & ankle care
- In November 2023, Smith+Nephew acquired CartiHeal, the developer of the Agili-C implant, in a deal valued at USD 330 million. This acquisition aligns with Smith+Nephew's strategic focus on investing in its sports medicine business and incorporating innovative technology into its portfolio
- In November 2022, Enovis launched the DynaNail Helix fixation system, designed to treat bone fractures, joint fusion, and bone reconstruction. This system features an advanced design that provides improved bone alignment, strength, and flexibility during surgery. It aims to enhance surgical precision and patient outcomes by reducing complications and recovery time
- In January 2023, Zimmer Biomet acquired Embody, Inc., a company specializing in bioresorbable materials for soft tissue repair. The acquisition strengthens Zimmer Biomet’s presence in sports medicine and orthopedic devices, particularly in tendon and ligament repair. Embody's innovative technologies complement Zimmer Biomet’s existing portfolio, focusing on minimally invasive treatments for faster recovery
